The Role of mTOR Inhibitors and PI3K Pathway Blockade in Renal Cell Cancer

Authors: A Benedetti De
A Boulay
A Crowe
A Lampen
A O’Donnell
A Perotti
A Soni
AI Sanchez-Fructuoso
AJ Pantuck
AM Arsham
AM Molina
BI Rini
BI Rini
C Sessa
C Tanaka
C Vezina
CJ Potter
CJ Punt
CJ Sabers
CP Eng
DA Fruman
DA Guertin
DD Sarbassov
DD Sarbassov
DH Kim
DP Houchens
E Avizienyte
E Galanis
E Raymond
EJ Brown
F Latif
FJ Dumont
G Hudes
G Iyer
GG Chiang
GI Kirchner
GV Thomas
H Dudek
H Sugiyama
HH Neumayer
HJ Eisen
J Brugarolas
J Brugarolas
J Chen
J Heitman
J Pascual
J Tabernero
JD Richter
JJ Zimmerman
JK Maranchie
JM Garcia-Martinez
JM Kovarik
JM Kovarik
JM Kovarik
JM Peralba
JM Tang
JP Boni
JP Boni
JS Skotnicki
K Hara
K Inoki
K Yu
KE O’Reilly
L Parry
LS Harrington
LW Ellison
M Hidalgo
M Mahalingam
M Sattler
MB Atkins
MB Dilling
MN Fishman
MP Byfield
MS Neshat
MW Albers
N Hay
N Paulsen de
OJ Shah
PH Patel
PH Patel
PJ Taylor
R Loewith
RJ Amato
RJ Motzer
RJ Motzer
RJ Motzer
RJ Motzer
RR Martel
RT Abraham
RY Calne
S Kourembanas
S Negrier
S Wullschleger
SB Helliwell
SC Clifford
SN Sehgal
SO Marx
SP Chawla
T Kobayashi
T Nobukuni
T Seufferlein
T Strom
TE Hutson
TM Mekhail
V Grunwald
VA Robb
W Brenner
W Jacobsen
WY Kim
X Wan
Y Shi
Y Shiloh
Z Feng
Publication date: 1 January 2015
Publisher: 'Springer Science and Business Media LLC'
Doi

Abstract

Abstract is not available.

Similar works

Full text

thumbnail-image

Available Versions

Crossref

redirect

info:doi/10.1007%2F978-3-319-1...

Last time updated on 03/08/2021